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Flock house virus (FHV) is a small icosahedral insect virus of the family Nodaviridae. Its genome consists of two
positive-sense RNA molecules, RNA1 (replicase gene) and RNA2 (coat protein gene), which are encapsidated into a single
virion. Expression of coat protein in Sf21 cells using a baculovirus vector results in formation of virus-like particles (VLPs)
whose capsids are structurally indistinguishable from native virions. However, RNA packaging is not specific for RNA2, the
coat protein message. Using ribonuclease protection assays, we showed that the fraction of RNA2 in VLPs is 19% relative
to the amount present in a population of native virions. To investigate possible reasons for the reduced level of RNA2, we
generated two new baculovirus vectors, AcR1 and AcR2, expressing the replicase gene and the coat protein gene,
respectively. The inserted genes carried the self-cleaving hepatitis delta ribozyme sequence at the 3 end to allow for
synthesis of RNA1 and RNA2 transcripts with authentic 3 ends. Infection of Sf21 cells with AcR2 yielded VLPs that
contained 66% RNA2 relative to native virions. Coinfection of Sf21 cells with AcR1 and AcR2 launched self-directed FHV
replication and resulted in formation of particles most of which contained RNA1 and RNA2. However, a small fraction of
particles containing cellular RNA was detected as well. The latter particles could be eliminated by infecting Sf21 cells with
AcR1 followed by transfection with in vitro synthesized transcripts of RNA2. We have further utilized this system to show
that two coat protein deletion mutants with distinct RNA packaging defects form mosaic virus capsids but do not complementKey Words: Flock house virus; RNA replication; virus-like
INTRODUCTION
Flock house virus (FHV) is a nonenveloped, icosahe-
dral insect virus of the family Nodaviridae. Its genome
consists of two messenger-sense RNA molecules, RNA1
and RNA2, which are packaged into a single virion
(Krishna and Schneemann, 1999). RNA1 (3107 nucleo-
tides) encodes protein A (112 kDa), the RNA-dependent
RNA polymerase (Friesen and Rueckert, 1981; Gallagher
et al., 1983). RNA2 (1400 nucleotides) encodes protein
alpha (44 kDa), the precursor of the coat protein (Friesen
and Rueckert, 1981). A subgenomic RNA (RNA3, 387
nucleotides) derived from the 3 end of RNA1 is gener-
ated in FHV-infected tissue culture cells (Ball, 1995;
Guarino et al., 1984) but is not packaged into virions. It
encodes two small non-structural proteins, B1 and B2.
While the precise function of B1 is not known, B2 has
recently been demonstrated to be a suppressor of RNA
silencing in animal and plant cells (Li et al., 2002).
Studies on FHV assembly in cultured Drosophila mela-
nogaster cells have shown that 180 subunits of alpha
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protein assemble to form a labile, noninfectious precur-
sor particle called provirion (Gallagher and Rueckert,
1988). Assembly into provirions catalyzes a maturation
event in which the alpha protein subunits (407 amino
acids) cleave between residues Asn363 and Ala364 to
yield mature coat proteins beta (363 amino acids) and
gamma (44 amino acids) (Gallagher and Rueckert, 1988;
Schneemann et al., 1992). The structure of mature FHV
particles was determined to high resolution by X-ray
crystallography (Fisher and Johnson, 1993). It provides
detailed insights into the organization of the protein cap-
sid but reveals little about the structure and organization
of the encapsidated RNAs.
The mechanism by which RNA1 and RNA2 are co-
packaged is currently unknown. We have previously
demonstrated that expression of the coat protein in Sf21
cells using a recombinant baculovirus vector results in
formation of virus-like particles (VLPs) that show normal
maturation kinetics and are crystallographically indistin-
guishable from wild-type (wt) virions (Schneemann et al.,
1993). However, RNA packaging in these VLPs is not
specific for RNA2, the coat protein message. The lack of
specific RNA2 packaging in this system could be attrib-
uted to at least three factors: (i) specific packaging of
RNA2 may be dependent on the presence of RNA1; (ii)each other to rescue specific packaging of FHV RNAs. ©
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transcription from the baculovirus DNA does not gener-
ate enough RNA2 for specific packaging; and (iii) heter-2002 Els
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ologous sequences at the 5 and 3 ends of RNA2 inter-
fere with specific recognition. Heterologous sequences
are particularly prominent at the 3 end of the RNA2
transcripts. This is due to the fact that transcription from
the baculovirus template continues beyond the natural
end of the RNA2 insert until a baculoviral transcription
termination signal is encountered. This and the addition
of a poly(A) tail result in formation of transcripts that are
approximately 2100 bases in length, considerably longer
than the 1400 bases comprising native RNA2. The pres-
ence of these heterologous nucleotides as well as the
increased length of the transcripts could interfere with
specific encapsidation of RNA2.
In an attempt to discern between these possibilities,
we generated two new recombinant baculoviruses, one
of which carried the cDNA of RNA1 and the other which
carried the cDNA of RNA2. In addition, both inserts
contained the sequence of the hepatitis delta virus (HV)
self-cleaving ribozyme (Perrotta and Been, 1991) imme-
diately adjacent to their 3 ends. The rationale for includ-
ing the HV ribozyme sequence was to promote synthe-
sis of transcripts that had authentic 3 ends and essen-
tially wt lengths except for a few heterologous
nucleotides at the 5 ends. Here we report that infection
of Sf21 cells with the RNA1-encoding baculovirus pro-
duced biologically active FHV polymerase that efficiently
recognized and replicated its own message. Coinfection
of Sf21 cells with the RNA1- and RNA2-encoding bacu-
loviruses resulted in formation of particles that copack-
aged RNA1 and RNA2 with high fidelity but a fraction of
particles containing cellular RNAs remained. The latter
particles could be largely eliminated by infecting the
cells with the RNA1-encoding baculovirus followed by
transfection with an in vitro synthesized RNA2 transcript.
We have utilized this system to show that two coat
protein deletion mutants with distinct RNA packaging
defects form mosaic virus capsids but do not comple-
ment each other to rescue specific packaging of FHV
RNAs.
RESULTS
Figure 1 shows a schematic representation of the
three recombinant baculoviruses used in this study.
AcR2, a construct previously described as Acwt
(Schneemann et al., 1993), contained the cDNA of FHV
RNA2 under control of the polyhedrin promoter. Although
the inserted gene is only 1.4 kb in length, the resulting
mRNA is approximately 2100 nucleotides long due to the
lack of a transcription termination signal at the end of the
FIG. 1. Schematic representation of recombinant baculoviruses carrying the full-length cDNAs of FHV RNA2 and RNA1. AcR2, a previously described
construct (Schneemann et al., 1993), has the cDNA of RNA2 (1400 nucleotides) positioned 73 nucleotides downstream of the polyhedrin transcriptional
start site (indicated by filled triangle). RNA transcription proceeds approximately 500 nucleotides beyond the end of the RNA2 sequence due to lack
of termination and polyadenylation signals in the inserted gene. Addition of a poly(A) tail results in a transcript of about 2100 nucleotides. AcR2 has
the cDNA of RNA2 positioned 58 nucleotides downstream of the polyhedrin transcriptional start site. Located immediately adjacent to the 3 end of
the cDNA insert is the 84 nucleotide HV ribozyme sequence (black bar). Autocatalytic cleavage of primary transcripts at the HV ribozyme site results
in FHV RNAs that have authentic 3 ends. AcR1 is analogous to AcR2. It has the cDNA of RNA1 (3107 nucleotides) positioned 67 nucleotides from
the polyhedrin transcriptional start site and the HV ribozyme sequence at its 3 end.
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FHV insert. The increased size of the transcript does not
affect the properties of the capsid protein because trans-
lation relies on the native start and stop codons of RNA2.
The name of this construct was changed from Acwt to
AcR2 to maintain a consistent nomenclature in the study
reported here. AcR2 was similar to AcR2 but contained
the 84 nucleotide sequence of the HV self-cleaving
ribozyme directly adjacent to the 3 end of the cDNA
insert. As shown by Ball (1995), transcripts containing
this sequence at the indicated position undergo autocat-
alytic cleavage to yield RNAs with authentic 3 ends.
AcR1 was analogous to AcR2 but contained the cDNA
of RNA1.
Synthesis of FHV RNAs in recombinant
baculovirus-infected Sf21 cells
To determine whether recombinant baculoviruses
AcR1 and AcR2 would give rise to detectable levels of
RNA1 and RNA2 in susceptible insect cells, Sf21 cells
were infected with the respective viruses at a multiplicity
of infection (m.o.i.) of 10 plaque forming units (PFUs) per
cell. Five days postinfection total cellular RNA was puri-
fied from the infected cells and analyzed by agarose gel
electrophoresis. RNA obtained from mock-infected cells
did not show any evidence for the presence of RNA1 or
RNA2 (Fig. 2, Lane 2). In contrast, Sf21 cells infected with
AcR1 contained an RNA species that comigrated with
native FHV RNA1 (Fig. 2, Lane 3). This RNA species was
present at a much higher level than most other cellular
RNAs. Interestingly, the cells also contained high levels
of a smaller RNA that had the molecular size of RNA3,
the subgenomic RNA derived from RNA1 (Fig. 2, Lane 3).
Since synthesis of the subgenomic RNA requires repli-
cation of FHV RNA1, the data implied that AcR1-infected
cells contained biologically active FHV polymerase. Ap-
parently, the polymerase protein, translated from either
the primary or the cleaved RNA transcripts, recognized
its baculovirus-derived message as a template for am-
plification and concurrent synthesis of RNA3. The obser-
vation that infection of Sf21 cells with AcR1 led to
replication of FHV RNA was unexpected because re-
peated attempts to induce FHV RNA replication in these
cells by transfection with purified RNA1 and RNA2 had
been unsuccessful (data not shown).
When total RNA from cells infected with AcR2 was
analyzed, RNA2 transcripts could not be detected among
the background of cellular RNAs (Fig. 2, Lane 4). That the
RNA was present, however, was later demonstrated by
Northern blot analysis (see below). Moreover, the cells
contained large amounts of FHV coat protein and FHV
VLPs (see below), further suggesting that RNA2 tran-
scripts were synthesized in the infected cells.
It was reasonable to assume that coinfection of Sf21
cells with AcR1 and AcR2 would lead to replication
and therefore increased levels of RNA2 if the FHV repli-
case was able to act in trans on AcR2-derived tran-
scripts. Indeed, analysis of total RNA from coinfected
cells showed that high levels of all three FHV RNAs were
now present (Fig. 2, Lane 5). Compared to AcR1-in-
fected cells, the levels of RNA3 were somewhat reduced.
This could be attributed to the presence of RNA2, which
is known to downregulate the synthesis of RNA3 (Zhong
and Rueckert, 1993). Thus, not only did the AcR1/AcR2
coinfected Sf21 cells contain biologically active FHV
polymerase but the regulation of RNA synthesis was
reminiscent of that observed in FHV-infected Drosophila
cells.
Northern blot analysis of total RNA from recombinant
baculovirus-infected Sf21 cells
To provide formal proof that FHV RNAs replicated in
AcR1-infected or AcR1/AcR2-coinfected Sf21 cells,
we performed Northern blot analysis using the same
total cellular RNA samples described above. Northern
blot analysis was also useful to evaluate the efficiency
with which the primary RNA1 and RNA2 transcripts
cleaved at the HV ribozyme site. RNA samples were
electrophoresed through 1% agarose–formaldehyde
gels, transferred to nylon membranes, and separately
FIG. 2. Electrophoretic analysis of total cellular RNA isolated from
Sf21 cells infected with recombinant baculoviruses. Sf21 cell monolay-
ers (8  106 cells) were infected with the indicated recombinant
baculoviruses at an m.o.i. of 10. Five days postinfection, total cellular
RNA was purified from the infected cells and an aliquot of 1 g was
size fractionated on a non-denaturing 2% SeaKem LE agarose–TAE gel.
RNAs were visualized with ethidium bromide. Lane 1, RNA molecular
size markers; Lane 2, total RNA from uninfected Sf21 cells; Lane 3, total
RNA from cells infected with AcR1; Lane 4, total RNA from cells
infected with AcR2; Lane 5, total RNA from cells coinfected with AcR1
and AcR2; Lane 6, RNA extracted from authentic FHV particles. The
molecular size of the RNA markers (in nucleotides) is indicated to the
left. The positions of RNA1, RNA2, and RNA3 are indicated to the right.
Note that under these electrophoresis conditions the molecular size
markers did not accurately reflect the sizes of the FHV RNAs. Also,
RNA1 in Lane 6 migrated slightly faster than RNA1 in Lanes 3 and 5.
This is an artifact presumably resulting from the large amount of
ribosomal RNAs in samples loaded in Lanes 3 and 5.
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hybridized to full-length ()-sense and ()-sense RNA1
and RNA2 probes. As shown in Fig. 3, hybridization with
a ()-sense RNA1 probe readily revealed the presence
of ()-sense RNA1 and RNA3 in AcR1-infected cells
and AcR1/AcR2-coinfected cells (top left, Lanes 2 and
4). The major RNA1 species comigrated with a positive
control sample represented by RNA1 from purified FHV
particles (Lane 5). A weaker RNA1 band of slightly higher
molecular weight was also detected and presumably
represented the uncleaved primary precursor. Several
smaller RNAs were observed that migrated between
RNA1 and RNA3. The identity of these species is cur-
rently unknown. They may have been breakdown prod-
ucts of RNA1 or perhaps RNA1-derived defective inter-
fering RNAs that were generated during RNA1 replica-
tion.
Analysis of the same samples with a ()-sense RNA1
probe confirmed the presence of both ()-sense RNA1
and ()-sense RNA3 in AcR1-infected and AcR1/
AcR2-coinfected cells (top right, Lanes 2 and 4). This
proved that RNA replication indeed occurred in the in-
fected cells. The band migrating at about 6300 nucleo-
tides presumably represented an RNA1 dimer as previ-
ously reported (Albarino et al., 2001). Similarly, a dimer
for RNA3 was present at about 780 nucleotides.
Hybridization with a ()-sense RNA2 probe confirmed
the presence of ()-sense RNA2 in cells infected with
AcR2 or coinfected with AcR1 and AcR2 (bottom left,
Lanes 3 and 4, respectively). Several bands were de-
tected in each sample. The major band in AcR2-infected
cells migrated as a 2100 nucleotide species, indicating
that it represented the uncleaved precursor molecule.
This transcript was analogous to the 2100 base mRNA
previously observed in cells infected with the baculovi-
rus AcR2 (Schneemann et al., 1993). A second signal was
detected below the major band at approximately 1900
nucleotides and a third signal was detected at approxi-
mately 4500 nucleotides. The reason for this collection of
transcripts is not entirely clear but it is known that tran-
scription from the polyhedrin promoter can terminate at
multiple downstream sites thereby giving rise to more
than one transcript (Friesen and Miller, 1985). Only a very
faint band was detected at 1400 nucleotides, suggesting
that cleavage of the primary RNA2 transcripts at the HV
ribozyme site was inefficient at best (Note: this band is
barely detectable on the reproduction shown here but
was visible on the original film.) However, the creation of
such small amounts appeared to be sufficient for recog-
nition and amplification by the RNA polymerase since the
1400 nucleotide transcript was the dominant species in
FIG. 3. Northern blot analysis of total cellular RNA isolated from Sf21 cells infected with recombinant baculoviruses. Sf21 cell monolayers (8  106
cells) were infected with the indicated recombinant baculoviruses at an m.o.i. of 10. Five days postinfection, total cellular RNA was purified from the
infected cells and aliquots of 100 ng were size fractionated on a 1% agarose–formaldehyde gel and transferred to a nylon membrane. Following UV
cross-linking, the immobilized RNAs were separately hybridized to digoxigenin–UTP-labeled negative- (left) and positive-sense (right) RNA probes
complementary to RNA1 (top) and RNA2 (bottom). Hybridization complexes were visualized by chemiluminescence. Lane 1, total RNA from uninfected
Sf21 cells; Lane 2, total RNA from cells infected with AcR1; Lane 3, total RNA from cells infected with AcR2; Lane 4, total RNA from cells coinfected
with AcR1 and AcR2; Lane 5, RNA extracted from authentic FHV particles (only 50 ng was loaded). The position of the RNA molecular size markers
(in nucleotides) is indicated to the left of each blot and the positions of RNA1, RNA2, and RNA3 are indicated to the right.
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cells coinfected with AcR2 and AcR1 (Lane 4). As
already observed for RNA1, the doubly infected cells
contained smaller RNA2-derived species. Since these
were not detected in cells infected with AcR2 alone, it is
perhaps more likely that they represented some sort of
defective-interfering RNAs that were generated during
the replication process.
Last, hybridization with a ()-sense RNA2 probe gave
rise to a signal only in cells coinfected with both AcR1
and AcR2 (bottom right, Lane 4). The presence of ()-
sense RNA2 confirmed that RNA2 was undergoing rep-
lication in these cells. An intense band migrating at
about 2800 nucleotides was most likely an RNA2 dimer
that has been previously reported (Albarino et al., 2001).
As with RNA1, other intermediate bands of unknown
origin were detected, possibly representing replicating
defective-interfering RNAs of RNA2.
RNA content and infectivity of FHV particles
generated in Sf21 cells from recombinant
baculovirus vectors
The goal of the next set of experiments was to deter-
mine the RNA packaging phenotype of particles gener-
ated in recombinant baculovirus-infected Sf21 cells. To
this end, Sf21 cells were either infected with AcR2 or
AcR2, or they were coinfected with AcR1 and AcR2.
Five days postinfection particles were harvested from
the cells and purified by sucrose gradient sedimentation.
The particles obtained from the three different cultures
sedimented at the same rate on sucrose gradients ex-
hibited similar ratios of optical absorbance at 260 and
280 nm and showed normal coat protein maturation
(data not shown). Extraction of the packaged RNA and
analysis by agarose gel electrophoresis showed that
particles generated from AcR2 contained a heteroge-
neous mixture of RNAs that ranged in size from approx-
imately 4500 to 100 nucleotides (Fig. 4, Lane 2). This
result was identical to our previous observations
(Schneemann et al., 1993). Particles generated from
AcR2 contained the same broad range of differently
sized RNAs (Fig. 4, Lane 3), suggesting that synthesis of
RNA2 transcripts having essentially wt length and au-
thentic 3 ends was not sufficient for specific packaging
into FHV particles.
An interesting result was obtained for particles puri-
fied from AcR1/AcR2-coinfected cells. As shown in Fig.
4, Lane 4, the RNA packaging phenotype of these parti-
cles was almost identical to that of native FHV particles;
FIG. 4. Electrophoretic analysis of RNA extracted from various types of FHV particles. RNA was extracted with phenol–chloroform from
gradient-purified virions and an aliquot of 1 g was electrophoresed through a non-denaturing 1% agarose–TAE gel. Nucleic acids were visualized
with ethidium bromide. Lane 1, RNA molecular size markers (in nucleotides); Lane 2–4, RNA isolated from particles generated in Sf21 cells infected
with recombinant baculovirus AcR2 (Lane 2), AcR2 (Lane 3), or coinfected with AcR2 and AcR1 (Lane 4). Particles whose RNA contents are shown
in Lanes 2 and 3 were designated VLPs because they are not infectious and cannot give rise to progeny virions. Particles whose RNA contents are
shown in Lane 4 were designated FHVbac because they contained the FHV genome and were infectious to Drosophila cells. Lanes 5–6: RNA isolated
from particles generated in Drosophila cells infected with FHVbac (Lane 5) or native FHV particles (Lane 6).
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however, some cellular RNA was visible as well. Since
many of the particles seemed to contain a complete FHV
genome, we tested whether they were infectious to Dro-
sophila cells (Schneider’s line 1, DL-1), which are used
for routine propagation of native FHV. Indeed, the AcR1/
AcR2-derived virions were infectious with a specific
infectivity of 4.6  1010 PFU/mg (Fig. 5). This titer was
approximately fourfold lower than the specific infectivity
of native virions determined in parallel (2.0  1011 PFU/
mg, Fig. 5). The lower value for the baculovirus-derived
particles was presumably a reflection of the fact that a
certain fraction of them contained cellular rather than
viral RNA. Taken together, these results demonstrated
that FHV particles almost indistinguishable in their phys-
ical and biological properties from authentic virions can
be generated in a heterologous expression system using
baculovirus vectors. To distinguish such particles from
the VLPs obtained from AcR2- or AcR2-infected cells,
they were called FHVbac. As expected, a single passage
of FHVbac through Drosophila cells eliminated the small
amount of cellular RNA present (Fig. 4, Lane 5) and the
resulting population of virions, designated FHVbac–Pass1,
was indistinguishable from native virions with regard to
specific infectivity (2.0  1011 PFU/mg for FHVbac–Pass1,
Fig. 5).
Quantification of RNA1 and RNA2 packaging in native
and recombinant FHV particles
Visualization of extracted RNAs in ethidium bromide
stained agarose gels provided a qualitative estimate of
the amount of RNA1 and RNA2 contained in the recom-
binant particles. To obtain more quantitative information
and to be able to compare different particle types, we
utilized a ribonuclease protection assay (RPA) with
probes complementary to positive strands of RNA1 and
RNA2. The RNA1 probe was complementary to the first
500 nucleotides of RNA1 while the RNA2 probe was
complementary to the first 300 nucleotides of the RNA2.
Both probes were radiolabeled with [32P]UTP to permit
quantification of the results by phosphorimaging.
As shown in Fig. 6A, each probe gave rise to a single
band after electrophoresis through a polyacrylamide gel
(Lanes 2 and 4, respectively), while there was no signal
in the presence of RNase A/T1 (Fig. 6A, Lanes 1 and 3).
In addition, there was no signal when the probes were
mixed together and subjected to RNase digestion, indi-
cating that the probes did not interact with each other
(data not shown). To generate a standard curve for quan-
tification of RNA1 and RNA2 in recombinant particles,
increasing amounts of purified viral RNA from native FHV
particles was subjected to the RPA. As seen in Fig. 6A
(Lanes 5–8) there was a slight shift in the size of the
protected RNA1 and RNA2 fragments compared to the
controls (Lanes 2 and 4). This shift was due to the
digestion of 30 nucleotides of nonhomologous sequence
contained at the 5 and 3 ends of the probes. The
observed shift in size validated that viral RNA within the
sample was protecting the probe and that the observed
signal was not due to an artifact.
Next, 10 ng aliquots of RNA extracted from recombi-
nant particles were analyzed using the same assay (Fig.
6A, Lanes 9–16). VLPs generated from AcR2 yielded a
signal for RNA2 (Fig. 6A, Lanes 9 and 10) that corre-
sponded to approximately 19% of the level of RNA2
detected in native FHV particles, whereas VLPs pro-
duced from AcR2 contained substantially more RNA2
(Fig. 6A, Lanes 11 and 12), approximately 66% the level of
RNA2 in native FHV (Fig. 6B). Thus, even though the
cleavage at the HV ribozyme site was not very efficient
in Sf21 cells, the shorter RNA2 transcripts were more
efficiently encapsidated than the longer RNA2 transcripts
produced by AcR2. As expected, no protected fragment
for RNA1 was observed in the AcR2 and AcR2 produced
VLPs and the rest of the RNA packaged in these particles
consisted of cellular RNA. These findings demonstrated
that RNA2 can be encapsidated in the absence of RNA1
and that removal of heterogeneous sequences at the 3
end of RNA2 increases the efficiency of encapsidation. It
was surprising, however, that even though 66% of the
RNA packaged in AcR2-derived VLPs represented
RNA2, no band for RNA2 was visible on ethidium bro-
mide stained agarose gels (see Fig. 4, Lane 3). A possi-
ble explanation for this observation is discussed below.
In contrast to the VLPs produced from AcR2 and
AcR2, FHVbac particles packaged both RNA1 and RNA2
(Fig. 6A, Lanes 13 and 14). RNA1 was packaged at 50%
the level of RNA1 in native virions, whereas RNA2 was
present at 82% (Fig. 6B). The lower level of viral RNA
relative to native virions was consistent with gel electro-
phoretic analysis which suggested that these particles
packaged some cellular RNA (see Fig. 4, Lane 4).
FIG. 5. Relative infectivity of various types of FHV particles. The
specific infectivity of gradient-purified preparations of FHVbac,
FHVbac-Pass1, and FHVbac* is shown relative to the specific infectivity of a
reference preparation of gradient-purified native FHV (FHVnat, 2.0 10
11
PFU/mg).
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Elimination of nonviral RNAs from FHVbac particles
Gel electrophoretic analysis and RPA assay of RNAs
packaged by FHVbac particles indicated that a fraction of
the virions contained nonviral RNAs. This is not observed
for FHV particles synthesized in infected Drosophila
cells. We wondered whether the basis for this discrep-
ancy was the difference in the temporal regulation of
FHV protein and RNA synthesis in baculovirus-infected
Sf21 cells vs FHV-infected Drosophila cells. In FHV-in-
fected Drosophila cells, RNA synthesis occurs early in
infection, whereas maximum coat protein synthesis is
not reached until about 16 h postinfection (Gallagher and
Rueckert, 1988). This leads to a great excess of viral RNA
in the cells with viral coat protein being the limiting
macromolecule in viral assembly. In contrast, in AcR1/
AcR2-coinfected Sf21 cells, FHV coat protein is synthe-
sized immediately after activation of the polyhedrin pro-
moter at a point when RNA replication has not yet been
initiated. The newly synthesized coat protein presumably
does not remain unassembled but starts to randomly
package cellular RNA just as it does in cells that are
infected with AcR2 or AcR2 alone.
FIG. 6. Ribonuclease protection assay of RNA1 and RNA2 packaged in native and recombinant FHV particles. (A) RNA was extracted from FHV
particles and subjected to RNase protection with 32P-labeled probes to RNA1 (R1) and RNA2 (R2) as described under Materials and Methods. In the
presence of the RNase A/T1 cocktail (), the R1 and R2 probes were completely digested (Lanes 1 and 3, respectively). In the absence of the RNases
(), the probes were intact and served as markers for the RNA1 and RNA2 protected fragments (Lanes 2 and 4, respectively). To generated a standard
curve, increasing amounts of viral RNA extracted from native FHV were subjected to ribonuclease protection: Lane 5, 5 ng; Lane 6, 10 ng; Lane 7,
15 ng; Lane 8, 20 ng. Lanes 9–16 show duplicate results obtained for RNA (10 ng) packaged in recombinant particles: Lanes 9 and 10, VLP (AcR2);
Lanes 11 and 12, VLP (AcR2); Lanes 13 and 14, FHVbac; Lanes 15 and 16, FHVbac*. The position of the protected fragments for RNA1 and RNA2 is
indicated between the two autoradiograms. Note that the slight shift in migration of the RNA1 and RNA2 probes compared to the protected fragments
is due to the digestion of 30 nucleotides of nonhomologous sequence contained in the probes. (B) Quantification of results obtained in (A). Signals
obtained for protected fragments of RNA1 and RNA2 were quantified by phophorimaging and expressed as a percentage relative to the signals
obtained for RNA1 and 2 fragments from native virions. The numbers shown represent an average of two to four independent measurements and
standard deviations.
16 KRISHNA, MARSHALL, AND SCHNEEMANN
Based on the above hypothesis, a delay in coat protein
synthesis was expected to result in elimination of cellu-
lar RNA from FHVbac particles. To test this, we initially
attempted to infect Sf21 cells first with AcR1 and then
superinfect the cells with AcR2 at later time points.
However, this strategy was unsuccessful because the
cells became resistant to superinfection once they had
been infected with AcR1 (data not shown). To circum-
vent this problem, the coat protein gene was introduced
into AcR1-infected Sf21 cells by liposome-mediated
transfection of capped in vitro synthesized wt RNA2 tran-
scripts. Specifically, Sf21 cells were infected at an m.o.i.
of 5 with AcR1 and 24 h postinfection, when FHV poly-
merase was present and replicating RNA1, the cells were
transfected with in vitro synthesized RNA2. The cells
were then incubated at 27°C and 4 days later recombi-
nant particles were purified by sucrose gradient sedi-
mentation. As with the other preparations, the particles
generated by infection/transfection, designated FHVbac*,
behaved identically to authentic FHV in their sedimenta-
tion on sucrose gradients, optical absorbance at 260 and
280 nm, and coat protein maturation (data not shown).
Extraction of the encapsidated RNA and analysis by
agarose gel electrophoresis showed that the particles
contained RNA1 and RNA2 (Fig. 7, Lane 3) similar to
native FHV (Fig. 7, Lane 4) and cellular RNA was not
detectable anymore. More rigorous analysis by RPA,
however, indicated that the RNA1 content was slightly
lower (93%) than in native virions, whereas the RNA2
content was higher (119%) (Fig. 6B). The increased
amount of RNA2 relative to RNA1 was also apparent
upon closer inspection of the agarose gel. Typically, the
RNA1 band appears brighter since a larger amount of
ethidium bromide intercalates into the longer RNA (Fig. 7,
Lane 4). RNA extracted from FHVbac* particles, however,
showed a slightly more intense band for RNA2 than for
RNA1. A difference between native virions and FHVbac*
particles was also observed by plaque assay. While the
specific infectivity of native virions was 2.0  1011 PFU/
mg, that of FHVbac* was slightly lower at 1.7  10
11
PFU/mg (Fig. 5), corresponding to a drop of 15%.
The data obtained by RPA suggested that FHVbac* par-
ticles contained little, if any, cellular RNA. This is be-
cause the level of RNA2 would be expected to increase
to 114% to compensate for the 7% drop in the level of
RNA1 (Note: each strand of RNA1 (3107 bases) would be
replaced by two strands of RNA2 (1400 bases).). The
value observed, 119%, was close to the one expected.
Coexpression of two coat protein mutants with
distinct RNA packaging defects
We next set out to determine whether two FHV coat
protein mutants that have distinguishable defects in
packaging FHV RNA could form mosaic particles in
which the RNA packaging phenotype was restored to the
normal complement of RNA1 and RNA2. To this end we
used an N-terminal deletion mutant (31 mutant) in
which residues 2–31 are deleted and a C-terminal mu-
tant (381 mutant) in which residues 382–407 are de-
leted. The N-terminal mutant packages normal levels of
RNA1 but reduced amounts of RNA2. The lack of RNA2 is
compensated for by cellular RNAs and defective-interfer-
ing RNAs of the viral RNAs (Marshall and Schneemann,
2001). The C-terminal mutant packages mostly random
RNAs and some viral RNA (Schneemann and Marshall,
1998). The different packaging phenotypes of the two
deletion mutants suggested that the N- and C-terminus
might have separate functions in specific recognition of
RNA1 and RNA2. This raised the question whether intact
termini had to be present on the same coat protein
subunit or whether formation of mosaic particles con-
taining both types of deletion mutants would result in
rescue of the wt encapsidation phenotype.
To address this question, we first needed to establish
that the mutant coat proteins were able to form mosaic
capsids when expressed in the same cell. This required
modification of one of the two proteins because both
form T  3 capsids that are expected to have identical
surface features since the deleted regions are located in
the viral interior. To be able to confirm the formation of
mosaic particles, the eight amino acid FLAG epitope was
inserted into the 31 protein between residues 205 and
206, which form part of a prominent loop on the surface
of the particle (Fisher and Johnson, 1993). We next gen-
erated particles using the infection/transfection method
described above. Cells were first infected with AcR1
and transfected 24 h later with a combination of two in
vitro synthesized RNA2 transcripts encoding either the
31/FLAG protein or the C-terminally deleted 381 coat
FIG. 7. Electrophoretic analysis of RNAs extracted from three differ-
ent types of FHV particles. RNA was extracted with phenol–chloroform
from gradient-purified virions and an aliquot of 1 g was electropho-
resed through a non-denaturing 1% agarose–TAE gel. Nucleic acids
were visualized with ethidium bromide. Lane 1, RNA molecular size
markers; Lane 2, RNA extracted from FHVbac particles generated in
AcR1/AcR2 coinfected Sf21 cells; Lane 3, RNA extracted from FHVbac*
particles generated in Sf21 cells first infected with AcR1 and then
transfected with wt RNA2 transcripts; Lane 4, RNA extracted from
native FHV particles. The molecular size of the RNA markers (in nucle-
otides) is indicated to the left of the figure. The positions of RNA1 and
RNA2 are indicated to the right.
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protein. As a control, cells were also transfected with the
C- or N-terminal deletion mutant alone. Five days post
infection, particles were purified through sucrose gradi-
ents and allowed to fully mature. Aliquots comprising
T  3 particles for 31/FLAGbac*, 381bac*, a mixture of
both mutant particles and the particles produced by
cotransfection, were incubated with a monoclonal anti-
body that specifically reacts with the FLAG epitope. The
immune complexes were then washed and subjected to
electrophoresis and immunoblot analysis using FHV an-
tibodies. As expected, 31/FLAGbac* particles were im-
munoprecipitated efficiently by the anti-FLAG monoclo-
nal sera (Fig. 8, Lane 1). In addition to the major coat
protein, beta, two smaller bands were detected which
are probably breakdown products. Such bands are com-
monly detected for wt FHV as well. In contrast, 381bac*
particles were not immunoprecipitated (Fig. 8, Lane 2).
Consistent with these results, when the two mutant par-
ticles were mixed together and subjected to immunopre-
cipitation, only 31/FLAG protein was detected (Fig. 8,
Lane 3). However, when the two coat proteins were
synthesized in the same cell, both 381 and 31/FLAG
protein were detected upon precipitation of particles
with the FLAG antibody and Western blot analysis with
FHV antiserum (Fig. 8, Lane 4). This suggested that the
two proteins had formed mosaic capsids. Note, however,
that the particles appeared to contain a larger amount of
381 protein, suggesting that the insertion of the FLAG
epitope into the 31 protein may have interfered with
efficient incorporation of this subunit into the capsid.
We next generated particles to investigate the RNA
encapsidation phenotype. To this end, the same strategy
as described above was used except that the 31/FLAG
construct was replaced with the 31 construct lacking
the heterologous epitope. Cells were first infected with
AcR1 and transfected 24 h later with a mixture of two in
vitro synthesized RNA2 transcripts encoding the mutant
coat proteins. As a control, cells were also transfected
with the C- or N-terminal deletion mutant alone to con-
firm that the resulting particles exhibited the same RNA
packaging defects that we had previously observed in
the Drosophila system (Schneemann and Marshall, 1998;
Marshall and Schneemann, 2001). Figure 9, Lane 2,
shows the encapsidation phenotype of the 381bac*
particles on an ethidium bromide stained agarose gel. As
expected, the particles contained a mixture of cellular
and viral RNAs. Quantification of the level of viral RNA in
the 381bac* particles revealed that 23% of RNA1 and
55% of RNA2 were present relative to wt FHV (Fig. 10).
The encapsidation phenotype of the 31bac* particles
was also as observed before (Fig. 9, Lane 3). The parti-
cles contained normal levels of RNA1 (96% that of wt
FHV) but subnormal levels of RNA2 (55% that of wt FHV)
(Fig. 10). Since the 31 RNA2 carried a deletion at the 5
end to remove the coding region for amino acid residues
2–31, the probe used for RPA was digested to a smaller
fragment than seen in the other examples. To accurately
quantitate the amount of 31 RNA2 in the particles, a
standard curve was therefore generated with in vitro
synthesized 31 RNA2 transcripts.
Last, analysis of the extracted RNA frommosaic particles
FIG. 8. Immunoprecipitation and immunoblot analysis of mutant
particles synthesized in Sf21 cells by infection/transfection protocol.
Monolayers of Sf21 cells in six-well tissue culture plates were infected
at an m.o.i. of 5 with recombinant baculovirus AcR1 and 24 h postin-
fection were separately transfected with capped RNAs encoding either
31/FLAG, 381, or a mixture of both mutant RNAs. Five days postin-
fection T  3 particles were isolated by sucrose gradient purification
and an aliquot was immunoprecipitated with a monoclonal antibody
specific for the FLAG epitope. The immune complexes were then
subjected to gel electrophoresis and followed by immunoblot analysis
with antisera to FHV. Lane 1, 31/FLAGbac* particles; Lane 2, 381bac*
particles; mixture of 31/FLAGbac* and 381bac* particles; Lane 4,
31/FLAGbac*/381bac* mosaic particles produced by cotransfection.
The position of 381 beta protein and 31/FLAG beta protein is as
indicated. The two bands migrating below the 31/FLAG beta protein
represent breakdown products commonly observed for FHV. Sample in
Lane 4 was overexposed relative to Lanes 1–3 to reveal the presence
of the 31/FLAG beta protein.
FIG. 9. Electrophoretic analysis of RNA extracted from particles
generated in Sf21 cells by the infection/transfection technique. RNA
was extracted with phenol–chloroform from gradient-purified virions
and electrophoresed through a non-denaturing 1% agarose–TAE gel.
Nucleic acids were visualized with ethidium bromide. Lane 1, RNA
molecular size markers; Lane 2, RNA extracted from 381bac* particles
generated by infecting Sf21 cells with AcR1 followed by transfection
with 381 transcripts; Lane 3, RNA extracted from 31bac* particles
generated by infecting Sf21 cells with AcR1 followed by transfection
with 31 transcripts; Lane 4, RNA extracted from (38131)bac*
particles generated by infecting Sf21 cells with AcR1 followed by
cotransfection with 381 and 31 transcripts; Lane 5, RNA extracted
from native FHV particles. The molecular size of the RNA markers (in
nucleotides) is indicated to the left of the figure. The positions of RNA1
and RNA2 are indicated to the right.
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revealed that the wt packaging phenotype had not been
restored (Fig. 9, Lane 4). Rather, the packaged RNAs ap-
peared to be a composite of the phenotypes observed for
the individual 31bac* and 381bac* mutants. Ribonuclease
protection revealed three protected fragments correspond-
ing to RNA1, 381-RNA2, and 31-RNA2 (Fig. 10A, Lanes
7 and 8). Quantification of these fragments showed that
RNA1 was present at a level of 57%, whereas 31 RNA2
and 381 RNA2 were present at a level of 48 and 82%,
respectively (Fig. 10B). These results suggested that the
FHV coat protein requires an intact N- and C-terminus on
the same subunit for specific packaging of RNA1 and
RNA2. However, other factors may account for the ob-
served data and they will be discussed below.
DISCUSSION
In this study we have shown that coinfection of Sf21
cells with AcR1 and AcR2 or infection with AcR1
followed by transfection with wt RNA2 transcripts re-
sulted in activation of FHV RNA replication and synthesis
of infectious FHV particles. The observation that AcR1
FIG. 10. Ribonuclease protection assay of RNA1 and RNA2 packaged in mutant and mosaic FHV particles. (A) RNA was extracted from FHV
particles and subjected to RNase protection assays with 32P-labeled probes to RNA1 (R1) and RNA2 (R2) as described in Fig. 6. Lanes 1 and 2, R1
and R2 probe only; Lanes 3 and 4, protected RNA from 31bac* particles. Note that the protected RNA2 fragment is smaller because the 31 RNA
contains a deletion in the area where the R2 probe binds. Lanes 5 and 6, protected RNA from 381bac* particles; Lanes 7 and 8, protected RNA from
(38131)bac* mosaic particles. Lane 9, protected RNA using an in vitro synthesized 31 RNA2 transcript to serve as a marker for the protected
fragment of 31RNA2 extracted from the recombinant particles in Lanes 3–4 and 7–8. (B) Quantification of results obtained in (A). Signals obtained
for protected fragments of RNA1 and RNA2 were quantified by phosphorimaging and expressed as a percentage relative to the signals obtained for
RNA1 and 2 fragments from native virions. The numbers shown represent an average of two to four independent measurements and standard
deviations.
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gave rise to biologically active FHV polymerase which
amplified its own message, synthesized the subgenomic
RNA3, and replicated RNA2 in trans was unexpected
because previous experiments in our laboratory had
hinted at a possible block of FHV RNA replication in Sf21
cells. For example, Sf21 cells could neither be produc-
tively infected with FHV particles nor did transfection
with purified viral RNAs result in any detectable levels of
progeny RNA1 or RNA2. While inability to infect Sf21 cells
could have been due to lack of a suitable cell surface
receptor, the inability to achieve FHV RNA synthesis by
transfection suggested that the cells lacked a host factor
that is required for replication. This seemed peculiar,
since FHV RNA replication is known to be quite promis-
cuous having been detected in a wide variety of trans-
fected cell types including insect cells (Gallagher et al.,
1983), mammalian cells (Ball et al., 1992), plant cells
(Selling et al., 1990), and yeast cells (Price et al., 1996). In
light of our new results it is clear that inability to achieve
replication of FHV RNAs in Sf21 cells must have had
other reasons. It is possible that the rate of RNA turnover
in Sf21 cells is higher than in Drosophila cells such that
the incoming RNAs were degraded before they could be
amplified by RNA replication. Alternatively, we consid-
ered the possibility that the baculovirus infection altered
the cellular environment in such a way that the normally
inactive FHV replicase became active. This scenario,
however, can be excluded since FHV RNA replication
could not be achieved in Sf21 cells that were infected
with an unrelated recombinant baculovirus (data not
shown). The most likely explanation for our results is that
constitutive expression of RNA1 from the polyhedrin pro-
motor produced such a high level of functional replicase
that factor(s) which normally might negatively influence
the activity of this enzyme could be overwhelmed.
The ability of the FHV polymerase to replicate RNA1
and RNA2 is greatly affected by the presence of terminal
extensions at the 5 and 3 ends of the viral transcripts.
As shown previously (Ball, 1995; Ball and Li, 1993), the
presence of 26 nonviral bases at the 5 end and 43
nonviral bases at the 3 end completely inhibits replica-
tion of RNA1 and RNA2. Based on these results it is
unlikely that the primary RNA1 and RNA2 transcripts
generated from the baculovirus genome could have
served as templates for replication by the FHV polymer-
ase since they would have contained several hundred
nonviral nucleotides at their 3 ends. It is more likely that
the templates were the products generated by cleavage
at the HV ribozyme site. Nonetheless, even cleaved
transcripts carried a significant number of nonviral bases
at the 5 ends: 67 nonviral bases at the 5 end of RNA1
and 58 nonviral bases at the 5 end of RNA2 (see Fig. 1).
Obviously, this did not inhibit their replication, suggesting
that the sequence and structural requirements for the 5
ends may be less stringent than previously appreciated.
Primer extension analysis showed that the nonviral
bases at the 5 end were eliminated by the polymerase
during the course of replication such that progeny RNA
molecules had authentic 5 ends (data not shown). This
phenomenon has been observed previously for FHV as
well as other RNA viruses (Boyer and Haenni, 1994;
Dasmahapatra et al., 1986).
The studies reported here were initiated to identify
parameters that affect specific packaging of FHV RNAs
into VLPs. We first considered the possibility that the
length of the FHV transcripts might affect packaging.
Indeed, RPA analysis showed that VLPs derived from
AcR2, which yielded RNA2 transcripts that closely re-
semble native RNA2 in length and sequence, contained
a significantly higher proportion of this RNA than VLPs
derived from AcR2, which yielded transcripts that are
much longer than native RNA2. The increase in specific
packaging, however, was not apparent on ethidium bro-
mide stained agarose gels which showed that both types
of VLPs contained a highly heterodisperse mixture of
RNAs that ranged in size from several hundred bases to
about 4500 bases. Based on results from a previous
study (Schneemann et al., 1993), which showed that
much of the RNA2 packaged in VLPs derived from AcR2
is degraded, we suspect that degradation may also have
occurred for RNA2 in VLPs derived from AcR2. The
reason for this is currently unknown and requires further
analysis.
We also investigated whether simultaneous expres-
sion of RNA1 and RNA2 promoted specific packaging of
FHV RNAs. Unexpectedly, coinfection of Sf21 cells with
AcR1 and AcR2 launched self-directed FHV RNA rep-
lication that was reminiscent of the replication observed
in FHV-infected Drosophila cells. Moreover, FHV parti-
cles harvested from the coinfected cells had encapsi-
dated FHV RNA1 and RNA2 with high fidelity. Because of
the ongoing replication of the FHV RNAs, we could not
evaluate whether the presence of RNA1 per se promoted
specific packaging or whether it was due to parameters
resulting from the replication. Preliminary experiments
indicate that the synthesis of RNA1 and RNA2 from
baculovirus vectors in the absence of replication is not
sufficient for specific packaging. For example, coinfec-
tion of cells with AcR2 and an AcR1 mutant that pro-
duced an inactive FHV polymerase yielded VLPs whose
RNA packaging phenotype was indistinguishable from
that obtained with AcR2 and AcR2 (data not shown).
The results obtained thus suggest that there may be
an encapsidation advantage of RNAs produced by rep-
lication. However, the situation is unlikely to be analo-
gous to picornaviruses for which it has been demon-
strated that only newly replicated RNA is packaged (Nu-
gent et al., 1999). This is because in vitro assembly
experiments have shown that FHV coat protein prefer-
entially packages FHV RNA when presented with a mix-
ture of viral and heterologous RNAs (Schneemann, 1992).
The replication advantage therefore may be due to other
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reasons. For example, RNA synthesized by replication in
the cytoplasm is likely to be present in a more suitable
conformation for packaging than RNA transcripts that are
synthesized in the nucleus from the baculovirus genome.
Nuclear synthesis not only requires transport of the tran-
scripts to the cytoplasm but also involves proteins that
bind to the RNAs such that recognition and packaging by
the coat protein may be prevented. Second, replication
results in much higher levels of the FHV RNAs than
transcription from the baculovirus genome and it may
occur in a local environment that could be important for
assembly and RNA encapsidation. Last, we cannot ex-
clude the possibility that temporal regulation of FHV
macromolecular synthesis is an important component of
specific packaging, based on our observation that the
infection/transfection protocol resulted in elimination of
the small amount of nonviral RNAs from FHVbac particles.
The ability to generate FHV particles essentially indis-
tinguishable from native virions in the baculovirus ex-
pression system prompted us to explore whether coat
proteins with distinct RNA encapsidation defects could
complement each other to rescue the wt packaging phe-
notype. This idea was based on the notion that more
than one coat protein subunit might be involved in spe-
cific recognition of RNA1 and RNA2. For example, it was
possible that the 381 mutant would specifically rec-
ognize RNA2 with its intact N terminus, while the 31
mutant would recognize RNA1 and that together these
proteins would produce capsids containing the normal
FHV genome. Mosaic capsids assembled from these
proteins, however, did not specifically package FHV
RNAs, suggesting that these two particular mutants can-
not complement each other. Alternatively, an in vivo sys-
tem may not be appropriate to address the question at
issue. For example, if recognition of RNA1 or RNA2
involves a coat protein oligomer rather than a single
subunit, formation of mixed oligomers may interfere with
the recognition process. Since formation of mixed oli-
gomers cannot be prevented, complementation may
never be observed, even if possible in principle. Based
on computational studies, it has been proposed that the
assembling building block of the FHV particle represents
a coat protein trimer (Reddy et al., 1998). The question of
whether multiple coat protein subunits are involved in
FHV RNA recognition may thus be better addressed in an
in vitro assembly system, where such complications can
be avoided.
In summary, our results show that recombinant bacu-
loviruses can be used to generate highly infectious viri-
ons. This system therefore represents a viable alterna-
tive to study replication, assembly, and structure of vi-
ruses which cannot be propagated in cell culture due to
lack of a susceptible cell line. To our knowledge, there
has been one other report of synthesis of an apparently
authentic particle using a baculovirus vector (Delaney
and Isom, 1998). Delaney and Isom showed that a re-
combinant baculovirus containing the complete genome
of hepatitis B virus (HBV) gave rise to HBV particles in
infected HepG2 cells. In this case, expression of the HBV
genome relied on endogenous HBV promoters since
baculoviruses can enter but not replicate in mammalian
cells. The infectivity of the baculovirus-derived HBV par-
ticles could not be tested due to lack of a susceptible cell
line. Nonetheless, the particles appeared to have all the
properties associated with native HBV virions.
MATERIALS AND METHODS
Cells
Spodoptera frugiperda cells (line IPLB-Sf21) (Vaughn
et al., 1977) were propagated in TC100 medium supple-
mented with 10% heat-inactivated fetal bovine serum as
described previously (Schneemann et al., 1993). Dro-
sophila melanogaster cells (Schneider’s line 1, DL-1)
(Schneider, 1972) were grown as monolayers in Schnei-
der’s insect medium supplemented with 15% heat-inac-
tivated fetal bovine serum as described previously
(Friesen and Rueckert, 1981).
Construction of recombinant baculoviruses
Construction of AcR2 (previously called Acwt), a re-
combinant baculovirus containing the cDNA of FHV
RNA2 under control of the polyhedrin promoter, was
described elsewhere (Schneemann et al., 1993). Recom-
binant baculoviruses containing the cDNA of FHV RNA1
and RNA2 with the hepatitis delta virus ribozyme se-
quence at the 3 end of each gene (AcR1, AcR2) were
generated with the BacPAK baculovirus expression sys-
tem kit (Clontech). To generate AcR1, a DNA fragment
containing the cDNA of RNA1, was fused to the HV
ribozyme sequence at its 3 end subcloned from plasmid
FHV[1,0] (Ball, 1995) into baculovirus transfer vector
pBacPAK9 (Clontech). To this end, the DNA fragment was
first amplified by PCR with Pfu polymerase and primers
containing EcoRI-restriction sites. The PCR product was
then purified by agarose gel electrophoresis and the Qiaex
II purification kit (Qiagen), digested with EcoRI, and ligated
into EcoRI-digested transfer vector pBacPAK9. Following
transformation of competent DH5 cells, plasmid DNA
was isolated from several clones and the presence and
orientation of the inserted DNA was determined by di-
agnostic restriction endonuclease mapping. To generate
AcR2, the cDNA of FHV RNA2 was first amplified by
PCR with Pfu polymerase using plasmid p2BS()-wt
(Schneemann et al., 1992) as template. The 84 nucleotide
HV sequence was separately amplified using FHV[1,0]
as template. The two PCR products were purified by
agarose gel electrophoresis as described above and
used for overlap extension PCR to generate the full-
length product. This was possible because the primers
used in the initial PCR reactions were designed in such
21RNA PACKAGING OF FHV USING BACULOVIRUS VECTORS
a way that the 3 end of the PCR product representing
RNA2 and the 5 end of the PCR product representing the
HV sequence overlapped by 15 nucleotides. More de-
tailed information regarding this strategy will be provided
upon request. Primers employed in the overlap extension
PCR contained BamHI restriction sites. The full-length
PCR product was purified, digested with BamHI, and
ligated into BamHI-digested pBacPAK9. Following trans-
formation, plasmid DNA was isolated from several
clones and the presence and orientation of the inserted
DNA was determined by diagnostic restriction endonu-
clease mapping.
The generation of recombinant baculoviruses was car-
ried out according to the manufacturer’s protocols.
Briefly, transfer vector pBacPAK9, containing the gene for
RNA1, and RNA2 was mixed with Bsu36I-linearized
BacPAK6 baculoviral DNA (Clontech) and transfected
into Sf21 cells. Three days posttransfection, cell super-
natants were harvested and putative recombinant vi-
ruses were isolated by plaquing the supernatants once
on Sf21 cell monolayers. Individual plaque isolates were
amplified following confirmation of the presence and
expression of the inserted genes. For AcR1, this was
done by Northern blot analysis of total cellular RNA
extracted from infected cell lysates. Detection of RNA1
and RNA3 with a ()-strand RNA1 probe was taken as
confirmation that the gene of interest was present and
expressed. For AcR2, the presence and expression of
the inserted gene was verified by immunoblot analysis of
the infected cell lysates using a polyclonal FHV anti-
serum.
Infection of Sf21 cells
Monolayers consisting of 8  106 cells in 100-mm-
diameter tissue culture dishes were infected with recom-
binant baculoviruses at a m.o.i. of 5 or 10 PFUs per cell
(approximately 1–1.5 ml of virus stock). After 1 h at room
temperature with rocking, the virus was removed and 5
ml cell growth medium was added to each dish. The
plates were further incubated at 27°C without agitation.
Infection of Drosophila cells
Infections were carried out in suspension at a cell
density of 4  107 cells/ml. Specifically, 2.5 ml of such a
suspension in a conical tube was inoculated with virus at
a m.o.i. of 10 PFUs per cell. After 1 h at room temperature
with gentle agitation, the cell suspension was trans-
ferred to a 100-mm-diameter tissue culture dish contain-
ing 12.5 ml cell growth medium. Plates were further
incubated at 27°C without agitation.
Construction of plasmid p2BS()-31/FLAG
A version of plasmid p2BS()-31 (Dong et al., 1998)
containing the coding sequence for the eight amino acid
FLAG peptide (N-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-C)
between amino acid residues 205 and 206 of the coat
protein was generated by overlap extension PCR using
p2BS()-wt as a template. Both forward and reverse
primers were generated that encoded the FLAG peptide
sequence and annealed to the sequence of the RNA2
gene that corresponds to amino acids 206–211 and 205–
200, respectively. The forward primer was used along
with a reverse primer that annealed to the 3 end of the
RNA2 gene and carried a XbaI-restriction site. The re-
verse primer was used along with a forward primer that
annealed to nucleotides 400–420 of the RNA2 gene. The
two PCR products were purified by agarose gel electro-
phoresis and used for overlap extension PCR with the
two outside primers to generate the final PCR product.
This PCR product was purified, digested with ClaI (which
cuts at base 470 in the RNA2 gene), and XbaI and ligated
into the p2BS()-31that was previously digested with
ClaI and XbaI. Following transformation, plasmid DNA
was isolated from several colonies and partially se-
quenced to confirm that the FLAG insert was present.
In vitro transcription of RNA2 and deletion mutants
Plasmid p2BS()-wt containing a cDNA of the wt
RNA2 gene and its mutant versions p2BS()-31 (Dong
et al., 1998), p2BS()-381 (Schneemann and Marshall,
1998), and p2BS()-31/FLAG were linearized with XbaI
and used as templates for in vitro transcription of capped
RNAs as described previously (Schneemann and Mar-
shall, 1998).
Infection/transfection of Sf21 cells
Monolayers consisting of 1.5  106 cells in six-well
tissue culture plates were infected with the recombinant
baculovirus AcR1 at a m.o.i. of 5 PFUs per cell (0.5 ml of
virus stock). After 1 h at room temperature with rocking,
the virus was removed, 2 ml cell growth medium was
added to each dish, and the plates were further incu-
bated at 27°C without agitation. At 24 h postinfection, the
cell growth medium was removed and 1 ml serum-free
medium was added. RNA–liposome complexes for one
well of cells was prepared as follows: a 2 l volume of
Cellfectin (Gibco-BRL) at a concentration of 1 mg/ml was
diluted to 30 l with water in a polystyrene tube. In vitro
synthesized capped FHV RNA2 (100 ng) in 30 l water
was then added. The complexes were allowed to form at
room temperature for 15 min and were then applied
directly to the cells. After a 6-h incubation period at 27°C,
1 ml of complete growth medium was added to the cells.
Incubation at 27°C was continued for 4 days.
Purification of VLPs and infectious virions
For biochemical characterization, FHV particles were
purified from Sf21 cells 5 days after infection and from
Drosophila cells 2 days after infection. To this end, cell
monolayers were dislodged into the growth medium and
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the resulting suspension was made 0.5% in Nonidet P-40
and 0.1% in 2-mercaptoethanol. After incubation on ice
for 10 min, cell debris was pelleted in a Beckman JA-17
rotor at 13,800 g (10,000 rpm) for 10 min at 4°C. The
supernatant was treated with RNase A at a final concen-
tration of 10 g/ml at 27°C for 30 min. Particles were
then pelleted through a 1-ml 30% (wt/wt) sucrose cushion
in 50 mM HEPES (pH 7)–0.1% 2-mercaptoethanol–0.1%
bovine serum albumin–5 mM CaCl2 at 274,000 g (40,000
rpm) in an SW41 Ti rotor for 2.5 h at 11°C. The pellet was
resuspended in 50 mM HEPES (pH 7)–0.1% 2-mercapto-
ethanol–5 mM CaCl2 and layered onto a 11-ml 10–40%
(wt/wt) sucrose gradient in the same buffer. Particles
were sedimented at 274,000 g (40,000 rpm) for 1.5 h at
11°C and the virus band was harvested by either needle
puncture or fractionation on an ISCO gradient fractiona-
tor at 0.75 ml/min and 0.5 min/fraction.
RNA extraction from Sf21 cells and purified particles
Total cellular RNA was purified from Sf21 cells 5 days
postinfection with the RNeasy mini kit (Qiagen). Phenol–
chloroform extraction of RNA from purified FHV particles
was done as described previously (Schneemann and
Marshall, 1998).
Agarose gel electrophoresis and Northern blot
analysis
To analyze total RNA from Sf21 cells, RNA was elec-
trophoresed through a non-denaturing 2% SeaKem LE
agarose gel (FMC) in Tris-acetate-EDTA (TAE) buffer. For
analysis of RNA extracted from FHV particles, RNA was
electrophoresed through a non-denaturing 1% agarose–
TAE gel. In both cases, RNA was visualized with ethidium
bromide present in the gel. For Northern blot analysis,
RNA was electrophoresed through a denaturing 1% aga-
rose–formaldehyde gel and transferred to a nylon mem-
brane as previously described (Schneider et al., 1994).
Probes used for hybridization were digoxigenin–UTP-
labeled sense and antisense RNAs complementary to
RNA1 and RNA2. To synthesize positive-sense probes,
plasmids containing the cDNA of RNA1 (p1WD) and
RNA2 (p2BS()-wt) were linearized with XbaI and tran-
scribed in vitro with SP6 RNA polymerase for p1WD and
T3 RNA polymerase for p2BS()-wt. To synthesize neg-
ative-sense probes, p1WD was digested with BamHI and
p2BS()-wt was digested with AccI and both linearized
plasmids were transcribed in vitro with T7 RNA polymer-
ase. Digestion with BamHI and AccI gave rise to ()-
sense transcripts that lacked nucleotides 1–384 of RNA1
and nucleotides 1–123 of RNA2, respectively. Transcrip-
tion of digoxigenin–UTP-labeled RNA was performed ac-
cording to the manufacturer’s protocols (Boehringer
Mannheim).
Ribonuclease protection assay
Ribonuclease protection assays were performed on
RNA extracted from both native FHV produced in Dro-
sophila cells as well as on recombinant particles pro-
duced in Sf21 cells. Probes to detect positive-strand
RNA1 and RNA2 were generated by PCR. Briefly, reverse
primers containing the core T7 phage promotor were
synthesized to anneal to nucleotides 500–483 of the
cDNA of RNA1 (FHV[1,0]) and nucleotides 300–283 of the
cDNA of RNA2 (p2BS()-wt). In conjunction with forward
primers that annealed to the first 18 nucleotides of the
RNA1 and RNA2 cDNAs and using FHV[1,0] and
p2BS()-wt as templates, PCR products were generated
that correspond to the first 500 nucleotides of RNA1 and
the first 300 nucleotides of RNA2, respectively. In addi-
tion to the FHV-specific sequence, each PCR product
had 11 nucleotides of foreign sequence at the 5 end and
19 nucleotides corresponding to the T7 promotor se-
quence at the 3 end. Both RNA1 and RNA2 probes were
generated from the respective PCR products using the
T7 MAXIscript kit (Ambion). Transcription reactions were
carried out according to the manufacturer’s conditions
and contained 308 Ci [-32P]UTP/mmol of UTP. The la-
beled probes were purified by electrophoresis through a
denaturing 5% polyacrylamide Tris–borate–EDTA (TBE)-6
M urea gel (Bio-Rad) and eluted. Ribonuclease protec-
tion was performed using the RPA III Kit (Ambion). Briefly,
5–20 ng aliquots of RNA extracted from native FHV or 10
ng aliquots of RNA extracted from recombinant particles
were mixed with a threefold molar excess of RNA1 and
RNA2 probes along with 10 g of yeast RNA as carrier.
Samples were coprecipitated, resuspended in hybridiza-
tion buffer, and then denatured at 95°C for 3 min and
hybridized overnight at 56°C. RNase digestion was per-
formed at 37°C using the provided RNaseA/RNase T1
cocktail at a dilution of 1:100 for 30 min. The enzymes
were then inactivated and the RNA was precipitated and
resuspended in gel loading buffer. The entire sample
was electrophoresed through a denaturing 5% polyacryl-
amide–TBE–6 M urea gel and vacuum-dried onto filter
paper. Radioactivity associated with each sample was
quantified by phosphorImager analysis. The percentage
of RNA1 and RNA2 reported was determined by utilizing
a standard curve generated with known amounts of viral
RNA from native FHV particles.
Electrophoretic analysis of proteins and immunoblot
analysis
Protein electrophoresis and immunoblot analysis were
performed with discontinuous sodium dodecyl sulfate–
polyacrylamide gels as described previously (Dong et al.,
1998), with one modification: electrophoresis was for 90
min instead of 45 min.
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Immunoprecipitation of viral particles
Aliquots (100 l) of purified T  3 381bac* particles,
31/FLAGbac* particles, a mixture of both, or mosaic par-
ticles, were brought up to 1 ml in 50 mM HEPES buffer
(pH 7). ANTI-FLAG M2 monoclonal antibody (1 g, IgG1)
(Sigma) was added to each sample and incubated for 1 h
at 4°C on a rocking platform. Fifty micrograms of protein
G–agarose suspension (Roche) was then added to the
mixtures and incubated overnight at 4°C on a rocking
platform. Immune complexes were collected by centrifu-
gation for 20 s at 12,000 g in a microfuge; the supernatant
was removed and the samples were then resuspended
in 1 ml HEPES buffer and incubated for 20 min at 4°C on
a rocking platform. The immune complexes were once
again collected as above; the supernatant was removed
and the samples were resuspended in 20 l of electro-
phoresis buffer and then subjected to protein gel elec-
trophoresis and immunoblot analysis with antibodies to
FHV.
Plaque assay
Infectivity titers were determined on monolayers of
Drosophila cells as described elsewhere (Schneemann
et al., 1992).
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